|
|
||||||||||||||
|
|
|||||||||||||||
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
1 INSERM U 408, Hôpital Bichat-Claude Bernard, Paris, France
2 Service de Pneumologie, Hôpital Bichat-Claude Bernard, Paris, France
3 Service de Physiologie-Explorations Fonctionnelles, Hôpital Bichat-Claude Bernard, Paris, France
4 Service de Biochimie A, Hôpital Bichat-Claude Bernard, Paris, France
5 Service de Pneumologie, Hôpital Beaujon, Assistance Publique-Hôpitaux de Paris, France
6 Service de Chirurgie Thoracique, Hôpital Beaujon, Assistance Publique-Hôpitaux de Paris, France
Correspondence to:
Correspondence to:
Dr A Boutten
Laboratoire de Biochimie A, Hôpital Bichat-Claude Bernard, 46 rue Henri Huchard, 75870 Paris, Cedex 18, France; anne.boutten{at}bch.ap-hop-paris.fr
Background: The overexpression of interferon (IFN)
or interleukin (IL)-13 in the adult murine lung induces the development of changes that mirror human lung emphysema.
Methods: IL-13 and IFN
expression was determined in lung samples from five groups of patients: severe emphysema without
1-antitrypsin deficiency (SE+, n = 10); severe emphysema with
1-antitrypsin deficiency (SE, n = 5); mild localised emphysema (ME, n = 8); non-emphysema smokers (NE-S, n = 9), and non-emphysema non-smokers (NE-NS, n = 11). Lung IL-13 and IFN
mRNA were analysed by RT-PCR. Lung concentrations of IL-13 protein were assessed by ELISA.
Results: The expression of IFN
mRNA was similar in patients with or without emphysema. IL-13 mRNA was markedly decreased in the SE+ group compared with the SE (p = 0.04), ME (p = 0.02), and non-emphysema groups (p = 0.01). IL-13 mRNA correlated with forced expiratory volume in 1 second (r = 0.5, p = 0.04) and arterial oxygen tension (r = 0.45, p = 0.03) in emphysema patients. In contrast to the non-emphysematous lung, IL-13 protein was below the detection limit of the assay in most emphysematous lung homogenates.
Conclusion: The lung IL-13 content is reduced in patients with severe emphysema without
1-antitrypsin deficiency.
Keywords: emphysema; interleukin 13; interferon 
Relevant Article
Thorax 2004 59: 821a.
This article has been cited by other articles:
![]() |
K. F. Chung and I. M. Adcock Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction Eur. Respir. J., June 1, 2008; 31(6): 1334 - 1356. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Imaoka, T. Hoshino, S. Takei, T. Kinoshita, M. Okamoto, T. Kawayama, S. Kato, H. Iwasaki, K. Watanabe, and H. Aizawa Interleukin-18 production and pulmonary function in COPD Eur. Respir. J., February 1, 2008; 31(2): 287 - 297. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bonay, A. Boutten, and B. Crestani Cytokines in Pulmonary Emphysema: Can Results in Mice Be Translated to Humans? Am. J. Respir. Crit. Care Med., January 15, 2008; 177(2): 238 - 238. [Full Text] [PDF] |
||||
![]() |
P. J. Barnes Against the dutch hypothesis: asthma and chronic obstructive pulmonary disease are distinct diseases. Am. J. Respir. Crit. Care Med., August 1, 2006; 174(3): 240 - 243. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |